Literature DB >> 15848180

Apoptosis repressor with caspase recruitment domain (ARC) is expressed in cancer cells and localizes to nuclei.

Mi Wang1, Suparna Qanungo, Michael T Crow, Michiko Watanabe, Anna-Liisa Nieminen.   

Abstract

Apoptosis repressor with caspase recruitment domain is expressed at high levels in brain and myogenic tissues, consistent with a role to inhibit apoptosis in the terminally differentiated cells. Expression of ARC in cancers is not known. In this study, we reported that ARC was highly expressed in various non-myogenic and non-neurogenic human and rat cancer cell lines. Unexpectedly, ARC was localized almost exclusively to the nuclei of cancer cells, which was unlike the cytoplasmic localization of ARC in non-cancer cells. Furthermore, nuclear ARC in cancer cells did not co-localize with nucleolus protein of 30 kDa, an alternatively spliced ARC isoform. These findings indicate that ARC is distributed differently in cancer cells than non-cancer cells and thus might play a role in neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848180     DOI: 10.1016/j.febslet.2005.03.040

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  27 in total

1.  p53 initiates apoptosis by transcriptionally targeting the antiapoptotic protein ARC.

Authors:  Yu-Zhen Li; Dao-Yuan Lu; Wei-Qi Tan; Jian-Xun Wang; Pei-Feng Li
Journal:  Mol Cell Biol       Date:  2007-11-12       Impact factor: 4.272

Review 2.  Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage.

Authors:  Kartik Mani
Journal:  Heart Fail Rev       Date:  2008-06       Impact factor: 4.214

3.  Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML.

Authors:  Bing Z Carter; Yi Hua Qiu; Nianxiang Zhang; Kevin R Coombes; Duncan H Mak; Deborah A Thomas; Farhad Ravandi; Hagop M Kantarjian; Erich Koller; Michael Andreeff; Steven M Kornblau
Journal:  Blood       Date:  2010-11-01       Impact factor: 22.113

4.  Knockdown of apoptosis repressor with caspase recruitment domain (ARC) increases the sensitivity of human glioma cell line U251MG to VM-26.

Authors:  Qiong Wang; Ailin Li; Hong Wang; Jinhuan Wang
Journal:  Int J Clin Exp Pathol       Date:  2012-07-29

5.  A novel role for the apoptosis inhibitor ARC in suppressing TNFα-induced regulated necrosis.

Authors:  G Kung; P Dai; L Deng; R N Kitsis
Journal:  Cell Death Differ       Date:  2014-01-17       Impact factor: 15.828

6.  Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AML.

Authors:  P Y Mak; D H Mak; H Mu; Y Shi; P Ruvolo; V Ruvolo; R Jacamo; J K Burks; W Wei; X Huang; S M Kornblau; M Andreeff; B Z Carter
Journal:  Apoptosis       Date:  2014-04       Impact factor: 4.677

7.  Expression of the apoptosis repressor with caspase recruitment domain (ARC) in liver metastasis of colorectal cancer and its correlation with DNA mismatch repair proteins and p53.

Authors:  Csaba Tóth; Jeannine Meinrath; Esther Herpel; Jutta Derix; Jochen Fries; Reinhard Buettner; Peter Schirmacher; Sebastian Heikaus
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-31       Impact factor: 4.553

8.  The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling.

Authors:  Csaba Toth; Sarah Funke; Vanessa Nitsche; Anna Liverts; Viktoriya Zlachevska; Marcia Gasis; Constanze Wiek; Helmut Hanenberg; Csaba Mahotka; Peter Schirmacher; Sebastian Heikaus
Journal:  Cell Commun Signal       Date:  2017-05-02       Impact factor: 5.712

9.  Apoptosis Repressor With Caspase Recruitment Domain Ameliorates Amyloid-Induced β-Cell Apoptosis and JNK Pathway Activation.

Authors:  Andrew T Templin; Tanya Samarasekera; Daniel T Meier; Meghan F Hogan; Mahnaz Mellati; Michael T Crow; Richard N Kitsis; Sakeneh Zraika; Rebecca L Hull; Steven E Kahn
Journal:  Diabetes       Date:  2017-07-20       Impact factor: 9.461

10.  Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins.

Authors:  David S Ziegler; Renee D Wright; Santosh Kesari; Madeleine E Lemieux; Mary A Tran; Monish Jain; Leigh Zawel; Andrew L Kung
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.